SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-058927
Filing Date
2020-03-02
Accepted
2020-03-02 16:19:35
Documents
5
Effectiveness Date
2020-03-02

Document Format Files

Seq Description Document Type Size
1 S-8 d865737ds8.htm S-8 40388
2 EX-5.1 d865737dex51.htm EX-5.1 11568
3 EX-23.1 d865737dex231.htm EX-23.1 1787
4 GRAPHIC g865737snap0001.jpg GRAPHIC 3008
5 GRAPHIC g865737snap0002.jpg GRAPHIC 2031
  Complete submission text file 0001193125-20-058927.txt   62041
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236824 | Film No.: 20677088
SIC: 2834 Pharmaceutical Preparations